
Sign up to save your podcasts
Or


In October last year, the FDA announced a shortage of Adderall due to manufacturing delays.
Now six months later, there is a severe shortage of not just Adderall, but similar drugs that treat ADHD. And it’s wreaking havoc on the lives of the children and adults who have the disorder.
So, what's going on and what can be done to fix the problem? Dr. David Pate, former CEO of St. Luke's Health System and current member of the Idaho Coronavirus Task Force, joined Idaho Matters to talk more about the issue.
By Boise State Public Radio4.5
102102 ratings
In October last year, the FDA announced a shortage of Adderall due to manufacturing delays.
Now six months later, there is a severe shortage of not just Adderall, but similar drugs that treat ADHD. And it’s wreaking havoc on the lives of the children and adults who have the disorder.
So, what's going on and what can be done to fix the problem? Dr. David Pate, former CEO of St. Luke's Health System and current member of the Idaho Coronavirus Task Force, joined Idaho Matters to talk more about the issue.

91,297 Listeners

43,837 Listeners

38,430 Listeners

43,687 Listeners

38,950 Listeners

9,238 Listeners

4,022 Listeners

8,471 Listeners

12,130 Listeners

6,467 Listeners

4,696 Listeners

16,512 Listeners

11 Listeners

434 Listeners

9 Listeners